These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 16154916)
1. Pyrexia, anorexia, adipsia, and depressed motor activity in rats during systemic inflammation induced by the Toll-like receptors-2 and -6 agonists MALP-2 and FSL-1. Hübschle T; Mütze J; Mühlradt PF; Korte S; Gerstberger R; Roth J Am J Physiol Regul Integr Comp Physiol; 2006 Jan; 290(1):R180-7. PubMed ID: 16154916 [TBL] [Abstract][Full Text] [Related]
2. Macrophage-activating lipopeptide-2 (MALP-2) induces a localized inflammatory response in rats resulting in activation of brain sites implicated in fever. Knorr C; Hübschle T; Murgott J; Mühlradt P; Gerstberger R; Roth J Brain Res; 2008 Apr; 1205():36-46. PubMed ID: 18353287 [TBL] [Abstract][Full Text] [Related]
3. Effects of repeated injections of fibroblast-stimulating lipopeptide-1 on fever, formation of cytokines, and on the responsiveness to endotoxin in guinea-pigs. Greis A; Murgott J; Gerstberger R; Hübschle T; Roth J Acta Physiol (Oxf); 2009 Sep; 197(1):35-45. PubMed ID: 19309391 [TBL] [Abstract][Full Text] [Related]
4. Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by toll-like receptors 2 and 6. Okusawa T; Fujita M; Nakamura J; Into T; Yasuda M; Yoshimura A; Hara Y; Hasebe A; Golenbock DT; Morita M; Kuroki Y; Ogawa T; Shibata K Infect Immun; 2004 Mar; 72(3):1657-65. PubMed ID: 14977973 [TBL] [Abstract][Full Text] [Related]
5. Fever induction by systemic stimulation with macrophage-activating lipopeptide-2 depends upon TLR2 but not CD36. Welsch J; Hübschle T; Murgott J; Kirschning C; Rummel C; Gerstberger R; Roth J Innate Immun; 2012 Jun; 18(3):541-59. PubMed ID: 22042912 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the febrile response induced by fibroblast-stimulating lipopeptide-1 in guinea pigs. Greis A; Murgott J; Rafalzik S; Gerstberger R; Hübschle T; Roth J Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R152-61. PubMed ID: 17491112 [TBL] [Abstract][Full Text] [Related]
7. Peripheral and central cyclooxygenase (COX) products may contribute to the manifestation of brain-controlled sickness responses during localized inflammation induced by macrophage-activating lipopeptide-2 (MALP-2). Knorr C; Marks D; Gerstberger R; Mühlradt PF; Roth J; Rummel C Neurosci Lett; 2010 Jul; 479(2):107-11. PubMed ID: 20580659 [TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of TLR-2/6 ligation in pulmonary bacterial infection and immunization with Pseudomonas aeruginosa. Kerber-Momot T; Leemhuis D; Lührmann A; Munder A; Tümmler B; Pabst R; Tschernig T Inflammation; 2010 Feb; 33(1):58-64. PubMed ID: 19844782 [TBL] [Abstract][Full Text] [Related]
14. Dissociation between learning and memory impairment and other sickness behaviours during simulated Mycoplasma infection in rats. Swanepoel T; Harvey BH; Harden LM; Laburn HP; Mitchell D Brain Behav Immun; 2011 Nov; 25(8):1607-16. PubMed ID: 21635947 [TBL] [Abstract][Full Text] [Related]
15. Local pulmonary immune stimulation by the Toll-like receptor 2 and 6 ligand MALP-2 in rats is age dependent. Lührmann A; Grote K; Stephan M; Tschernig T; Pabst R Immunol Lett; 2007 Feb; 108(2):167-73. PubMed ID: 17275100 [TBL] [Abstract][Full Text] [Related]
16. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. Takeuchi O; Kaufmann A; Grote K; Kawai T; Hoshino K; Morr M; Mühlradt PF; Akira S J Immunol; 2000 Jan; 164(2):554-7. PubMed ID: 10623793 [TBL] [Abstract][Full Text] [Related]
17. Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial. Schmidt J; Welsch T; Jäger D; Mühlradt PF; Büchler MW; Märten A Br J Cancer; 2007 Sep; 97(5):598-604. PubMed ID: 17667928 [TBL] [Abstract][Full Text] [Related]